StockData
Bruker Corp logo

Bruker Corp (BRKR) stock

BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30440% above fair value
$61.59+1.26 (+2.09%)

Close on Nov 13, 2026Market cap $9.55BP/E –Yield –

Bruker cash

Cash and short-term investments held at the end of each period.

Bruker's cash was $119.70M at Sep 30, 2026. For fiscal 2025 it was $298.80M, up 60.0% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $1.17B in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$298.80M+60.0%
FY2024Dec 31, 2024$186.70M-62.0%
FY2023Dec 31, 2023$491.60M-24.2%
FY2022Dec 31, 2022$648.70M-44.6%
FY2021Dec 31, 2021$1.17B+59.3%
FY2020Dec 31, 2020$735.50M+6.8%
FY2019Dec 31, 2019$688.50M+111.0%
FY2018Dec 31, 2018$326.30M-26.4%
FY2017Dec 31, 2017$443.10M+28.1%
FY2016Dec 31, 2016$345.90M+27.5%
FY2015Dec 31, 2015$271.20M-15.1%
FY2014Dec 31, 2014$319.50M-27.2%
FY2013Dec 31, 2013$438.70M+41.2%
FY2012Dec 31, 2012$310.60M+26.3%
FY2011Dec 31, 2011$246.00M+6.8%
FY2010Dec 31, 2010$230.40M+11.3%
FY2009Dec 31, 2009$207.10M+24.6%
FY2008Dec 31, 2008$166.20M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$119.70M-59.7%
Q2 FY2026Jun 30, 2026$184.90M+92.2%
Q1 FY2026Mar 31, 2026$133.40M-28.9%
Q4 FY2025Dec 31, 2025$298.80M+60.0%
Q3 FY2025Sep 30, 2025$297.30M+96.0%
Q2 FY2025Jun 30, 2025$96.20M-44.5%
Q1 FY2025Mar 31, 2025$187.70M-45.3%
Q4 FY2024Dec 31, 2024$186.70M-62.0%
Q3 FY2024Sep 30, 2024$151.70M-58.7%
Q2 FY2024Jun 30, 2024$173.20M-70.0%
Q1 FY2024Mar 31, 2024$343.30M-42.9%
Q4 FY2023Dec 31, 2023$491.60M-24.2%
Q3 FY2023Sep 30, 2023$366.90M-41.7%
Q2 FY2023Jun 30, 2023$578.20M-20.4%
Q1 FY2023Mar 31, 2023$601.40M-34.6%
Q4 FY2022Dec 31, 2022$648.70M-44.6%
Q3 FY2022Sep 30, 2022$629.30M-6.5%
Q2 FY2022Jun 30, 2022$726.30M+2.4%
Q1 FY2022Mar 31, 2022$919.60M+22.5%
Q4 FY2021Dec 31, 2021$1.17B+59.3%
Q3 FY2021Sep 30, 2021$673.30M+8.5%
Q2 FY2021Jun 30, 2021$709.60M-11.3%
Q1 FY2021Mar 31, 2021$750.40M-12.2%
Q4 FY2020Dec 31, 2020$735.50M+6.8%
Q3 FY2020Sep 30, 2020$620.60M+102.7%
Q2 FY2020Jun 30, 2020$800.40M+173.4%
Q1 FY2020Mar 31, 2020$855.10M+182.6%
Q4 FY2019Dec 31, 2019$688.50M+111.0%
Q3 FY2019Sep 30, 2019$306.10M+11.4%
Q2 FY2019Jun 30, 2019$292.80M+11.5%
Q1 FY2019Mar 31, 2019$302.60M+5.1%
Q4 FY2018Dec 31, 2018$326.30M-26.4%
Q3 FY2018Sep 30, 2018$274.80M+2.6%
Q2 FY2018Jun 30, 2018$262.50M+18.6%
Q1 FY2018Mar 31, 2018$287.80M+2.5%
Q4 FY2017Dec 31, 2017$443.10M+28.1%
Q3 FY2017Sep 30, 2017$267.80M–
Q2 FY2017Jun 30, 2017$221.40M–
Q1 FY2017Mar 31, 2017$280.70M–
Q4 FY2016Dec 31, 2016$345.90M–

More Bruker figures

See a number that looks wrong?